Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels
Assessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range Without Promoting Constipation or Adverse Gastrointestinal Effects Among Healthy Premenopausal Women With Iron Deficiency Without Anemia
Sponsor: Applied Science & Performance Institute
Listed as NCT05257343, this NA trial focuses on Iron Deficiency (Without Anemia) and remains completed. Sponsored by Applied Science & Performance Institute, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2023 — Jul 2024 [monthly]
Completed NA
-
Apr 2023 — Jun 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2022 — Apr 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Mar 2022 — Sep 2022 [monthly]
Recruiting NA
First recorded
Feb 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Applied Science & Performance Institute
For direct contact, visit the study record on ClinicalTrials.gov .